Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside? | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Review

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	854	892	317
Jun 2022	547	598	341
Jul 2022	403	413	126
Aug 2022	417	433	126
Sep 2022	429	439	152
Oct 2022	385	404	115
Nov 2022	370	385	121
Dec 2022	290	295	100
Jan 2023	234	247	99
Feb 2023	281	284	104
Mar 2023	219	220	98
Apr 2023	181	184	79
May 2023	134	141	73
Jun 2023	177	183	60
Jul 2023	183	185	91
Aug 2023	145	146	50
Sep 2023	135	142	52
Oct 2023	306	314	134
Nov 2023	194	200	84
Dec 2023	161	165	43
Jan 2024	104	105	50
Feb 2024	173	176	60
Mar 2024	310	312	97
Total	6632	6863	2572